200 related articles for article (PubMed ID: 8925479)
1. Argon green vs. krypton red laser photocoagulation for extrafoveal choroidal neovascularization secondary to age-related macular degeneration: 3-year results of a multicentre randomized trial. Canadian Ophthalmology Study Group.
Willan AR; Cruess AF; Ballantyne M
Can J Ophthalmol; 1996 Feb; 31(1):11-7. PubMed ID: 8925479
[TBL] [Abstract][Full Text] [Related]
2. Argon green vs krypton red laser photocoagulation of extrafoveal choroidal neovascular lesions. One-year results in age-related macular degeneration. The Canadian Ophthalmology Study Group.
Arch Ophthalmol; 1993 Feb; 111(2):181-5. PubMed ID: 7679269
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of argon green vs krypton red laser for photocoagulation of subfoveal choroidal neovascularization in the macular photocoagulation study. Macular Photocoagulation Study (MPS) Group.
Arch Ophthalmol; 1994 Sep; 112(9):1176-84. PubMed ID: 7522004
[TBL] [Abstract][Full Text] [Related]
4. Occult choroidal neovascularization. Influence on visual outcome in patients with age-related macular degeneration. Macular Photocoagulation Study Group.
Arch Ophthalmol; 1996 Apr; 114(4):400-12. PubMed ID: 8602776
[TBL] [Abstract][Full Text] [Related]
5. Argon green vs krypton red laser photocoagulation for extrafoveal choroidal neovascularization. One-year results in ocular histoplasmosis. The Canadian Ophthalmology Study Group.
Arch Ophthalmol; 1994 Sep; 112(9):1166-73. PubMed ID: 7522003
[TBL] [Abstract][Full Text] [Related]
6. The influence of treatment extent on the visual acuity of eyes treated with Krypton laser for juxtafoveal choroidal neovascularization. Macular Photocoagulation Study Group.
Arch Ophthalmol; 1995 Feb; 113(2):190-4. PubMed ID: 7532395
[TBL] [Abstract][Full Text] [Related]
7. Feeder vessel photocoagulation of subfoveal choroidal neovascularization secondary to age-related macular degeneration.
Shiraga F; Ojima Y; Matsuo T; Takasu I; Matsuo N
Ophthalmology; 1998 Apr; 105(4):662-9. PubMed ID: 9544641
[TBL] [Abstract][Full Text] [Related]
8. Current management of choroidal neovascularization.
Singerman LJ
Ann Ophthalmol; 1988 Nov; 20(11):415-20, 423. PubMed ID: 2466432
[TBL] [Abstract][Full Text] [Related]
9. Laser photocoagulation for juxtafoveal choroidal neovascularization. Five-year results from randomized clinical trials. Macular Photocoagulation Study Group.
Arch Ophthalmol; 1994 Apr; 112(4):500-9. PubMed ID: 7512336
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of exudative age-related macular degeneration].
Yuzawa M
Nippon Ganka Gakkai Zasshi; 2000 Dec; 104(12):875-98. PubMed ID: 11193943
[TBL] [Abstract][Full Text] [Related]
11. Laser treatment in eyes with large drusen. Short-term effects seen in a pilot randomized clinical trial. Choroidal Neovascularization Prevention Trial Research Group.
Ophthalmology; 1998 Jan; 105(1):11-23. PubMed ID: 9442774
[TBL] [Abstract][Full Text] [Related]
12. Persistent and recurrent neovascularization after laser photocoagulation for subfoveal choroidal neovascularization of age-related macular degeneration. Macular Photocoagulation Study Group.
Arch Ophthalmol; 1994 Apr; 112(4):489-99. PubMed ID: 7512335
[TBL] [Abstract][Full Text] [Related]
13. [Progression of choroidal neovascularization after macular translocation in age-related macular degeneration and degenerative myopia].
Simon P; Glacet-Bernard A; Coscas G; Soubrane G
J Fr Ophtalmol; 2002 Sep; 25(7):694-700. PubMed ID: 12399725
[TBL] [Abstract][Full Text] [Related]
14. Macular scatter ('grid') laser treatment of poorly demarcated subfoveal choroidal neovascularization in age-related macular degeneration. Results of a randomized pilot trial.
Bressler NM; Maguire MG; Murphy PL; Alexander J; Margherio R; Schachat AP; Fine SL; Stevens TS; Bressler SB
Arch Ophthalmol; 1996 Dec; 114(12):1456-64. PubMed ID: 8953976
[TBL] [Abstract][Full Text] [Related]
15. Laser treatment for choroidal neovascularization outside randomized clinical trials.
Jost BF; Alexander MF; Maguire MG; Fine SL; Chamberlin JA; Murphy RP
Arch Ophthalmol; 1988 Mar; 106(3):357-61. PubMed ID: 2449884
[TBL] [Abstract][Full Text] [Related]
16. Recurrent choroidal neovascularization after laser photocoagulation in Sorsby's fundus dystrophy.
Holz FG; Haimovici R; Wagner DG; Bird AC
Retina; 1994; 14(4):329-34. PubMed ID: 7529420
[TBL] [Abstract][Full Text] [Related]
17. Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group.
Arch Ophthalmol; 1991 Sep; 109(9):1220-31. PubMed ID: 1718250
[TBL] [Abstract][Full Text] [Related]
18. Krypton laser photocoagulation for idiopathic neovascular lesions. Results of a randomized clinical trial. Macular Photocoagulation Study Group.
Arch Ophthalmol; 1990 Jun; 108(6):832-7. PubMed ID: 1693498
[TBL] [Abstract][Full Text] [Related]
19. Five-year follow-up of fellow eyes of individuals with ocular histoplasmosis and unilateral extrafoveal or juxtafoveal choroidal neovascularization. Macular Photocoagulation Study Group.
Arch Ophthalmol; 1996 Jun; 114(6):677-88. PubMed ID: 8639078
[TBL] [Abstract][Full Text] [Related]
20. Comparisons of photocoagulation treatment in exudative age-related macular degeneration with the blue-green argon, green argon and red krypton laser wavelengths.
Atmaca LS; Ozmert E; Gündüz K
Ophthalmologica; 1993; 207(1):46-54. PubMed ID: 7506402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
